Board of the Pension Protection Fund Makes New Investment in The Clorox Company (NYSE:CLX)

Board of the Pension Protection Fund purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,000 shares of the company's stock, valued at approximately $589,000.

Several other institutional investors also recently modified their holdings of CLX. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new stake in Clorox in the fourth quarter worth approximately $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox in the fourth quarter worth approximately $31,000. GKV Capital Management Co. Inc. bought a new stake in Clorox in the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Clorox during the 4th quarter valued at $33,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.57% of the company's stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research reports. Barclays dropped their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Jefferies Financial Group decreased their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday. Wells Fargo & Company lowered their price objective on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $149.50.

Clorox Stock Up 0.9%

NYSE:CLX traded up $1.08 during trading hours on Friday, reaching $119.09. The company's stock had a trading volume of 5,265,025 shares, compared to its average volume of 1,384,359. The stock has a 50 day moving average price of $131.62 and a two-hundred day moving average price of $145.61. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The company has a market capitalization of $14.68 billion, a P/E ratio of 21.38, a price-to-earnings-growth ratio of 2.70 and a beta of 0.54. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a net margin of 9.89% and a return on equity of 324.23%. The company's revenue was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.71 earnings per share. Equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.